APA (7th ed.) Citation

Zheng, A., Murray, E. J., Brennan, A. T., Greener, R., Kileel, E. M., Bor, J., . . . Maskew, M. (2026). One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials. Open Forum Infectious Diseases, 13(5), 1. https://doi.org/10.1093/ofid/ofag151

Chicago Style (17th ed.) Citation

Zheng, Amy, et al. "One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials." Open Forum Infectious Diseases 13, no. 5 (2026): 1. https://doi.org/10.1093/ofid/ofag151.

MLA (9th ed.) Citation

Zheng, Amy, et al. "One- and Two-Year Outcomes of Switching to a Dolutegravir-Based ART Regimen: An Observational Emulation of Sequential Target Trials." Open Forum Infectious Diseases, vol. 13, no. 5, 2026, p. 1, https://doi.org/10.1093/ofid/ofag151.